UPM Biomedicals
UPM Biomedicals is the forerunner in producing high quality nanofibrillar cellulose for medical and life science applications. More than 400 patents protect the existing and future products that rely on the Finnish birch pulp. They actively collaborate with universities, research centers and key industrial partners on future innovations and products in the field of high-throughput drug screening, personalized medicine, advanced cell therapies, 3D bioprinting, tissue engineering and advanced wound care.
